C12N 2840/206
Having multiple ires
Official title: having multiple IRES
C12N2840/206 (Having multiple ires) appears on 75 US grants and 118 published applications in this corpus.
Search patents in C12N- Granted patents
- 75
- Published applications
- 118
- Assignees
- 80
- Inventors
- 260
- Latest grant
- 30 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 4 | 0 |
| 1999 | 0 | 0 |
| 2000 | 5 | 0 |
| 2001 | 7 | 0 |
| 2002 | 5 | 7 |
| 2003 | 0 | 13 |
| 2004 | 5 | 11 |
| 2005 | 3 | 4 |
| 2006 | 1 | 11 |
| 2007 | 2 | 4 |
| 2008 | 3 | 1 |
| 2009 | 1 | 4 |
| 2010 | 2 | 5 |
| 2011 | 3 | 4 |
| 2012 | 1 | 3 |
| 2013 | 3 | 1 |
| 2014 | 2 | 3 |
| 2015 | 0 | 1 |
| 2016 | 5 | 4 |
| 2017 | 1 | 2 |
| 2018 | 5 | 5 |
| 2019 | 1 | 4 |
| 2020 | 4 | 3 |
| 2021 | 1 | 5 |
| 2022 | 3 | 8 |
| 2023 | 4 | 3 |
| 2024 | 1 | 5 |
| 2025 | 3 | 4 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- System and process for in vivo manufacturing nanostructure-ended double-stranded covalently-closed linear DNA, the resulting molecules and their uses30 Dec 2025US 12,509,711 B1Syste.Bio Inc.
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Replication-defective arenavirus vectors18 Feb 2025US 12,227,755 B2UniversitäT ZüRich
- Immunostimulating vector system5 Nov 2024US 12,133,898 B2Provecs Medical GmbH
- Expression system for expressing herpesvirus glycoprotein complexes19 Dec 2023US 11,844,833 B2City of Hope
- Circrna expression construct16 Jul 2026US 2026/0201369 A1
- Co-Expression of Constructs and Polypeptides9 Jul 2026US 2026/0193669 A1Nykode Therapeutics ASA
- Multicistron expression vector for covid-19 vaccine11 Jun 2026US 2026/0159553 A1Kashiv Biosciences, LLC
- Replication-defective arenavirus vectors4 Dec 2025US 2025/0369015 A1UniversitäT ZüRich
- Transcriptionally recording cell composition and method for non-invasive assessment of gut function30 Oct 2025US 2025/0333731 A1ETH Zurich
Most cited
By later US patents
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Alphavirus structural protein expression cassettes152US 5,789,245 AChiron Corporation · 1998
- Method for introducing and expressing RNA in animal cells143US 6,500,419 B1University of Maryland Biotechnology Institute · 2002
- Eukaryotic layered vector initiation systems126US 6,015,686 AChiron Viagene, Inc. · 2000